Centene Corporation (CNC)
NYSE: CNC · Real-Time Price · USD
62.12
+1.89 (3.14%)
At close: Apr 23, 2025, 4:00 PM
61.11
-1.01 (-1.63%)
Pre-market: Apr 24, 2025, 6:11 AM EDT
Centene Market Cap
Centene has a market cap or net worth of $30.82 billion as of April 24, 2025. Its market cap has decreased by -21.06% in one year.
Market Cap
30.82B
Enterprise Value
36.18B
1-Year Change
-21.06%
Ranking
Category
Stock Price
$62.12
Market Cap Chart
Since December 13, 2001, Centene's market cap has increased from $173.20M to $30.82B, an increase of 17,691.72%. That is a compound annual growth rate of 24.81%.
Market Cap History
Date | Market Cap | % Change |
---|---|---|
Apr 23, 2025 | 30.81B | 0.75% |
Dec 31, 2024 | 30.58B | -22.85% |
Dec 29, 2023 | 39.64B | -14.63% |
Dec 30, 2022 | 46.44B | -3.41% |
Dec 31, 2021 | 48.08B | 38.14% |
Dec 31, 2020 | 34.81B | 33.79% |
Dec 31, 2019 | 26.02B | 9.87% |
Dec 31, 2018 | 23.68B | 36.01% |
Dec 29, 2017 | 17.41B | 80.27% |
Dec 30, 2016 | 9.66B | 23.10% |
Dec 31, 2015 | 7.84B | 28.76% |
Dec 31, 2014 | 6.09B | 88.70% |
Dec 31, 2013 | 3.23B | 52.51% |
Dec 31, 2012 | 2.12B | 6.14% |
Dec 30, 2011 | 1.99B | 52.18% |
Dec 31, 2010 | 1.31B | 36.35% |
Dec 31, 2009 | 961.30M | 13.67% |
Dec 31, 2008 | 845.70M | -29.19% |
Dec 31, 2007 | 1.19B | 12.60% |
Dec 29, 2006 | 1.06B | -5.45% |
Dec 30, 2005 | 1.12B | -3.60% |
Dec 31, 2004 | 1.16B | 107.10% |
Dec 31, 2003 | 561.90M | 55.35% |
Dec 31, 2002 | 361.70M | 63.67% |
Dec 31, 2001 | 221.00M | 27.60% |
View and export this data all the way back to 2001.
Sign Up Today.
Market Capitalization
Market capitalization, also called net worth, is the total value of all of a company's outstanding shares. It is calculated by multiplying the stock price by the number of shares outstanding.
Formula: Market Cap = Stock Price * Shares Outstanding
Full DefinitionRelated Stocks
Company | Market Cap |
---|---|
Eli Lilly and Company | 733.68B |
UnitedHealth Group | 396.99B |
Johnson & Johnson | 376.49B |
AbbVie | 299.72B |
Novo Nordisk | 284.50B |
Abbott Laboratories | 223.92B |
Novartis AG | 209.93B |
AstraZeneca | 208.11B |